{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 58,
        "end": 68
      }
    },
    {
      "id": "T2",
      "obj": "Disease",
      "span": {
        "begin": 115,
        "end": 143
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 163,
        "end": 169
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 174,
        "end": 180
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 73,
        "end": 76
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "22555197_1",
  "text": "A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer : influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activity ."
}
